Luma Ghalib is an Endocrinology/Metabolic physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 48 publications with 228 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
543 Taylor Ave
Columbus, OH 432031278
Telephone
614-685-3333Provider last certified this registry record 9 Dec 2024.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
51.6%l-Thyroxine40.3%Levothyroxine Sodium93%Synthroid7%Part D≥138 patientsVasopressin Analog7.1%Desmopressin Acetate100%Part D<11 patients+ 3 more classes in this area
Sensory organs
15.4%Corticosteroid15.4%Hydrocortisone100%Part D≥49 patientsMetabolism & gastrointestinal
14.9%Corticosteroid4.1%Prednisone100%Part D≥18 patientsSGLT2 inhibitor3.7%Jardiance100%Part D≥12 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Novel Autoimmune Presentation of Wiskott‐Aldrich Syndrome: Type 1 Diabetes
Immunity Inflammation and Disease
2026 - Papillary craniopharyngioma management in the era of BRAF and MEK inhibition
Journal of Neuro-Oncology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Colleen Cebulla, MD
The Ohio State University Wexner Medical Center
Michael Grever, MD
The Ohio State University Wexner Medical Center
Brad Rovin, MD
The Ohio State University Wexner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”